about
Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugatesMacrophage-mediated cholesterol handling in atherosclerosisIL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.The role of oxidative stress and autophagy in atherosclerosisInhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol effluxThe autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.Nuclear receptors as drug targets for metabolic disease.Insulin and glucose play a role in foam cell formation and function.Macrophage PPAR gamma Co-activator-1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid.Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A.M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitisThe role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivoPhotosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorin(e6)Gene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways.Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.The 763C>G Polymorphism of The Secretory PLA2IIa Gene Is Associated with Endometriosis in Iranian WomenPodocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.Metabolic syndrome: the danger signal in atherosclerosis.Investigations on therapeutic glucocerebrosidases through paired detection with fluorescent activity-based probes.Survival of monocytes and macrophages and their role in health and disease.C/EBPβ in bone marrow is essential for diet induced inflammation, cholesterol balance, and atherosclerosis.Dynamics of lung macrophage activation in response to helminth infection.Analysis of inflammatory and lipid metabolic networks across RAW264.7 and thioglycolate-elicited macrophages.Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infectionHuman neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases.Leukocyte lipid bodies - Biogenesis and functions in inflammationHigh-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.A lipidomic perspective on inflammatory macrophage eicosanoid signaling.Carbamylated-oxidized LDL: proatherosclerotic effects on endothelial cells and macrophagesThe Role of Macrophage Lipophagy in Reverse Cholesterol TransportChlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.Blockade of human immunodeficiency virus type 1 expression by caveolin-1.HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.Coronary heart disease: Significance of liver X receptor α genomics.Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis
P2860
Q23909514-F420C68A-8316-4A90-9D53-29F6CB471E44Q26780405-2CF5D331-F261-49B8-BE02-686A5976A0E4Q27315329-289503B4-4D07-4D8D-B04F-FC27960F6F0EQ28085161-706493BC-8C7D-4619-85D1-759B471AF5F7Q28588482-479776BB-E720-41F3-916C-1404BFB65D68Q28591283-31371D66-728C-42C4-8588-BA148279FAB1Q30430126-0229F61E-C2C0-4307-BDFA-44FD92E50314Q30440798-0A3B600B-09E7-4A18-BCB7-0500093EC227Q30551530-3C1DC78E-D771-4288-B002-DF3F71A7F5B0Q33286823-509B36F3-E906-4152-85CD-D9090AF8E2BDQ33706866-73329C3C-3895-463F-9799-5A75F31589AFQ33784558-831301BF-635C-4DC0-8D05-F14BED9677F5Q33915925-F3939A76-9EAD-43DF-BF0B-C3237DEDA58FQ34116691-0EE5B494-0396-4AB9-A751-4CA43474B8BBQ34287053-964C99C1-0351-4862-BE88-7E9EB0979B55Q34603659-381331E1-BFD4-431F-8C29-49C8580FD308Q35166396-3F9C690E-A02C-4C36-9F1D-32B52F097BE2Q35931824-D06FA8CD-66A4-4D2A-ABB7-E38431D06CB4Q36012953-661BA2D6-DC96-4E3F-8356-7D4F3CEC4F7BQ36282478-182F7F5D-DB59-4ABD-AFDA-4ECF97D796FCQ37002380-30547E9E-C10F-4F46-A5DB-5A1DADB85AE1Q37004159-42FE37BE-5B0A-4AB3-ACE6-82B48800028EQ37039002-5927E8A6-E92F-4756-B2A7-752657E11EA4Q37076525-24637C32-3439-4918-91AA-42FC3D6D7A4FQ37123229-96361804-4539-4B9E-92C1-2FC419544384Q37275036-DA5B0934-0B8E-48F9-BE0C-7C3A6F902104Q37471003-1B0E73D7-8B8F-400C-9B46-EF44BAC1E010Q37611333-F75271BD-761C-4261-8D20-1793B62AE32AQ37624601-7FDD19CF-6910-4264-84F4-9537084445ACQ37693244-523C315E-51FE-4527-A348-6DD5FC5A3EF0Q37723252-B9792768-3C79-4CA6-9710-BCAE07ED73A0Q37860795-78149438-A9F1-4D22-AA17-4D1F8E6B9D16Q39684514-CCD1DE94-504B-43FA-9ED8-FA5136660A80Q39740926-B1E06298-4CC5-41AF-A260-CCF58BEE7718Q41137063-38CDE68F-A065-4643-8A61-11AF1991CC53Q57160461-490C1B81-6688-44D6-806A-23A2A35C99B4
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Macrophage scavenger receptors and foam cell formation.
@ast
Macrophage scavenger receptors and foam cell formation.
@en
type
label
Macrophage scavenger receptors and foam cell formation.
@ast
Macrophage scavenger receptors and foam cell formation.
@en
prefLabel
Macrophage scavenger receptors and foam cell formation.
@ast
Macrophage scavenger receptors and foam cell formation.
@en
P356
P1476
Macrophage scavenger receptors and foam cell formation
@en
P2093
W J de Villiers
P304
P356
10.1002/JLB.66.5.740
P577
1999-11-01T00:00:00Z